HDFC Mutual Fund Boosts Stake in Global Health via ₹130 Crore Deal
HDFC Mutual Fund has significantly increased its exposure to the healthcare sector by acquiring an additional 10 lakh shares of Global Health, the operator of the renowned Medanta hospital chain. This strategic move through open market transactions underscores the fund house's growing confidence in the company's long-term growth trajectory.
Deepening Exposure to Medanta’s Parent Company
In a substantial block deal executed on the BSE, HDFC Mutual Fund purchased 10 lakh shares of Global Health at an average price of ₹1,300 per share. This transaction, valued at approximately ₹130 crore, represents a 0.37 per cent stake in the healthcare major.
This acquisition follows a similar pattern of investment from the fund house; just last month, HDFC MF had already purchased 10 lakh shares from the same source for over ₹122 crore. The recurring nature of these purchases suggests a deliberate strategy to accumulate equity in the hospital operator.
Promoter Offloading and Stakeholder Shift
The shares were acquired from Sunil Sachdeva, a co-founder of Medanta Hospitals. By offloading these 10 lakh shares, Sachdeva has reduced his holding from the 2.90 crore equity shares (a 10.79 per cent stake) he held at the end of the March quarter.
While the stock saw a minor intraday dip of 0.41 per cent to close at ₹1,311.35 on the BSE following the news, the institutional interest from a major player like HDFC MF provides a significant liquidity cushion and a signal of fundamental strength to the broader market.
Robust Financial Performance Driving Investor Interest
The institutional appetite for Global Health is likely bolstered by the company's impressive financial performance reported in the recent fiscal cycles. For the fourth quarter ended March 31, 2026, Global Health demonstrated significant scale and profitability improvements.
The company reported a 39.7 per cent surge in Profit After Tax (PAT), reaching ₹141.7 crore, compared to ₹101.4 crore in the same period of the previous fiscal year. This growth was supported by a strong rise in top-line performance, with revenue from operations climbing to ₹1,159 crore from ₹931.3 crore in the year-ago quarter. Such double-digit growth in both revenue and profitability makes Global Health an attractive target for large-scale institutional investors looking for stability in the healthcare services segment.
Key Takeaways
- Strategic Accumulation: HDFC Mutual Fund has increased its stake in Global Health by 0.37% through a ₹130 crore deal, marking its second major purchase of these shares in two months.
- Promoter Transaction: The shares were acquired from co-founder Sunil Sachdeva, who sold the shares at an average price of ₹1,300 per unit.
- Strong Fundamentals: The investment comes on the back of Global Health's robust Q4 FY26 performance, which saw a nearly 40% jump in PAT and significant revenue growth.